Notice of Closed Meeting, 17412 [2019-08337]
Download as PDF
<![CDATA[
17412
Federal Register / Vol. 84, No. 80 / Thursday, April 25, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Administration for Children and
Families
Notice of Closed Meeting
Notice of Closed Meeting
Submission for OMB Review;
Comment Request
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–CE–19–002,
Research Grants to Identify Effective
Strategies for Opioid Overdose Prevention.
Date: June 25–26, 2019.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Hilton Garden Inn Atlanta—
Buckhead, 3342 Peachtree Road NE, Atlanta,
GA 30326
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Mikel
Walters, Ph.D., Scientific Review Official,
NCIPC, CDC, 4770 Buford Highway NE,
Mailstop F–63, Atlanta, Georgia 30341,
Telephone (404) 639–0913, MWalters@
cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—PAR 18–812, NIOSH
Member Conflict.
Date: June 27, 2019.
Time: 1:00 p.m.–4:00 p.m. EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Nina
Turner, Ph.D., Scientific Reviewer Officer,
Office of Extramural Programs, 1095
Willowdale Road, Morgantown, WV 26506,
(304) 285–5976, nxt2@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–08338 Filed 4–24–19; 8:45 am]
[FR Doc. 2019–08337 Filed 4–24–19; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
Title: National Evaluation of the
Sexual Risk Avoidance Education
(SRAE) Program.
OMB No.: [NEW].
Description: The Administration for
Children and Families (ACF) proposes a
data collection effort related to the
National Evaluation of the Sexual Risk
Avoidance Education (SRAE) Program—
National Descriptive Study.
The National Descriptive Study (of
the National Evaluation of the SRAE
Program) has multiple components.
This information collection request only
pertains to the Early Implementation
Study, which will provide an early
catalogue of SRAE programs’
implementation. ACF seeks approval to
collect the following information:
—Survey for Use with SRAE grantees.
The purpose of this collection effort is
to conduct surveys with
administrators/program directors in
each of the states/organizations that
received SRAE grants to better
understand what key decisions states/
organizations made regarding the
design of their SRAE-funded
programs and why they made those
decisions.
—Interview Guide for Use with SRAE
grantees. The purpose of this
collection effort is to conduct semistructured interviews, that follow-on
the surveys, with administrators/
program directors in each of the
states/organizations that received
SRAE grants: the interviews will offer
long-answer, qualitative responses to
key questions, to better understand
what key decisions states/
organizations made regarding the
design of their SRAE-funded
programs and why they made those
decisions.
Respondents: State level
administrators; Agency administrators;
Organization heads; Project directors.
khammond on DSKBBV9HB2PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
Survey for SRAE Grantees ..................................................
Interview Guide for SRAE Grantees ....................................
VerDate Sep<11>2014
16:25 Apr 24, 2019
Jkt 247001
PO 00000
Frm 00039
Annual
number of
respondents
85
85
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
28
28
E:\FR\FM\25APN1.SGM
1
1
25APN1
Average
burden hours
per response
1.5
1.5
Annual
burden
hours
42
42
]]>Agencies
[Federal Register Volume 84, Number 80 (Thursday, April 25, 2019)]
[Notices]
[Page 17412]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--PAR 18-812, NIOSH Member
Conflict.
Date: June 27, 2019.
Time: 1:00 p.m.-4:00 p.m. EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Nina Turner, Ph.D., Scientific
Reviewer Officer, Office of Extramural Programs, 1095 Willowdale
Road, Morgantown, WV 26506, (304) 285-5976, [email protected].
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-08337 Filed 4-24-19; 8:45 am]
BILLING CODE 4163-18-P
